It’s a deal that would create the world’s biggest seeds and pesticides company, with enormous power over the world’s food supply. German chemicals giant Bayer is paying a record $66bn dollars for Monsanto, the controversial biotech company largely known for developing genetically modified seeds for crops. Though such products are widely used in the US, plans to introduce them into Europe have previously prompted fierce protest from environmental activists. They’re not the only ones who might be opposed to the deal – farming groups and anti-competition regulators are likely to voice concerns. We look at whether the deal will happen and why Bayer is so keen to bet the farm on the GM agriculture sector.
Germany certainly deserves plaudits for the number of refugees it has taken in from war-torn countries like Syria in the last year – about a million at the last count – but how are they doing at one of the key planks of integration, namely employment? A survey by the Frankfurter Allgeme